Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.
about
Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cellsExpression profiles of histone lysine demethylases during cardiomyocyte differentiation of mouse embryonic stem cells.Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cellsProfiling deacetylase activities in cell lysates with peptide arrays and SAMDI mass spectrometry.Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells.Downregulation of HDAC1 is involved in the cardiomyocyte differentiation from mesenchymal stem cells in a myocardial microenvironment.Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem CellsHistone Deacetylases in Bone Development and Skeletal Disorders.Enhanced differentiation of mesenchymal stromal cells by three-dimensional culture and azacitidine.Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics.Histone deacetylases and their roles in mineralized tissue regenerationThe Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.TGF-β1 impairs mechanosensation of human osteoblasts via HDAC6-mediated shortening and distortion of primary cilia.Enhancement of human mesenchymal stem cell differentiation by combination treatment with 5-azacytidine and trichostatin A.Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules
P2860
Q28396209-8FC19095-E8C6-4159-832D-202989737577Q33869741-8F6880D8-DEE1-4250-BBE8-88EBCEB69F76Q34475885-AB1A6043-EC9B-4E05-B797-F09A00E858AFQ35006665-4156FE51-BB4B-495F-AF59-622AA3B66E56Q35073567-42F7E25F-E766-4740-9FC0-DC961117FC8AQ35137443-174BC052-92DF-4452-AAD9-F89377D90678Q36021958-0204B695-175B-445D-B504-14383D387BDBQ36146330-5B047DDE-438F-4198-9621-141A5A8185E0Q37740403-D1066703-93AA-4C3E-A259-F8B296596F22Q38402465-8A685CB9-2DF4-4243-9CE5-50AB982A6BEAQ38502939-02AF33BC-2C3C-4DED-BFEC-D227E5C7FA6DQ41479037-7C427499-8357-4F8F-A8DD-F171FBEDA852Q46280254-AD4B96AB-0C30-4F0C-AFAB-B698C8B394FDQ48152374-DFC20DE6-3CC3-4253-9DBE-D1F0AB80E03CQ53355865-BA5CEC1E-1117-4556-B278-8F8159572322Q55471455-A29BEB87-6E48-4D54-9012-708675F2AE92Q58618195-5665F49E-B891-4C26-8136-0071B3631D0E
P2860
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@en
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@nl
type
label
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@en
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@nl
prefLabel
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@en
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@nl
P2093
P2860
P356
P1476
Effect of the HDAC inhibitor v ...... ro and bone formation in vivo.
@en
P2093
Ann De Becker
Ben Van Camp
Gaia Cecilia Santini
Holly Evans
Isabelle Vande Broek
Ivan Van Riet
Karin Vanderkerken
Kim De Veirman
Peter Croucher
P2860
P2888
P304
P356
10.1038/APS.2012.182
P50
P577
2013-04-08T00:00:00Z
P5875
P6179
1026367757